Directory
>
David Rubinstein
David Rubinstein
Senior Vice President, Head of Business Development | MeiraGTx
Boston, Massachusetts, United States
David Rubinstein
Summary
David Rubinstein is an accomplished business development executive with a strong background in the biotechnology and pharmaceutical industries. Currently serving as the Senior Vice President and Head of Business Development at MeiraGTx, he has a proven track record of driving strategic partnerships and growth initiatives. David's earlier roles include leadership positions at Regeneron Pharmaceuticals and Genentech, where he contributed significantly to their genetic medicine and oncology pipelines. He holds an MBA from Harvard Business School and a PhD in Biochemistry and Molecular Biology from the Weizmann Institute of Science. David's diverse experience spans from intelligence operations in the Israeli Military to technology transfer roles, showcasing his adaptability and breadth of knowledge. His professional interests include innovation in gene therapy and the integration of emerging technologies in healthcare. David is passionate about shaping the future of medicine through strategic collaboration and scientific advancement.
David Rubinstein
Work Experience
Senior Vice President, Head of Business Development at
MeiraGTx
April 2023 - Present
Vice President, Business Development at
MeiraGTx
January 2021 - April 2023
Director, Business Development at
Regeneron
January 2015 - January 2021
Pipeline and Portfolio Planning MBA Intern at
Genentech
January 2014 - January 2014
Technology Transfer Officer at
YEDA - Technology Transfer Company of Weizmann Institute of Science
January 2011 - January 2013
Business Intelligence Analyst at
Adkit
January 2004 - January 2007
Intelligence Officer (Unit 8200) at
Israeli Military Intelligence
January 2001 - January 2004
David Rubinstein
Education
Harvard Business School, Master Of Business Administration (Mba)
Weizmann Institute of Science , Doctor Of Philosophy - Phd
Frequently Asked Questions about David Rubinstein
What is David Rubinstein email address?
David Rubinstein's primary email address is ***********@meiragtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Rubinstein work for?
David Rubinstein is a Senior Vice President, Head of Business Development at MeiraGTx, a company specializing in Commercial physical research.
Where David Rubinstein graduated from?
David Rubinstein holds a degree in from Harvard Business School.
How can I directly contact David Rubinstein?
To contact David Rubinstein directly, you can use the email address ***********@meiragtx.com. Complete contact information is available upon registration with Muraena.
Is David Rubinstein an immigrant?
Yes, David Rubinstein is an immigrant and currently based in United States
Who is David Rubinstein?
David Rubinstein is an accomplished business development executive with a strong background in the biotechnology and pharmaceutical industries. Currently serving as the Senior Vice President and Head of Business Development at MeiraGTx, he has a proven track record of driving strategic partnerships and growth initiatives. David's earlier roles include leadership positions at Regeneron Pharmaceuticals and Genentech, where he contributed significantly to their genetic medicine and oncology pipelines. He holds an MBA from Harvard Business School and a PhD in Biochemistry and Molecular Biology from the Weizmann Institute of Science. David's diverse experience spans from intelligence operations in the Israeli Military to technology transfer roles, showcasing his adaptability and breadth of knowledge. His professional interests include innovation in gene therapy and the integration of emerging technologies in healthcare. David is passionate about shaping the future of medicine through strategic collaboration and scientific advancement.
David`s contact details
***********@meiragtx.com
Colleagues
Vice President Preclinical Development
VP MSAT
Chief Operating Officer
Chief Medical Officer
Vice President, Salivary Gland Therapeutics Lead
Executive Director, CMC Regulatory Affairs
Chief Executive Officer
VP, Biostatistics
VP Clinical Research and Ophthalmology